Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 8 November

Sophia Mavridis
November 8, 2022

Closing Bell 7 November

Grady Wulff
November 7, 2022

Morning Bell 7 November

Grady Wulff
November 7, 2022

Weekly Wrap 4 November

Grady Wulff
November 4, 2022

Morning Bell 4 November

Grady Wulff
November 4, 2022

Closing Bell 3 November

Grady Wulff
November 3, 2022

Morning Bell 3 November

Grady Wulff
November 3, 2022

Closing Bell 2 November

Sophia Mavridis
November 2, 2022

Morning Bell 2 November

Sophia Mavridis
November 2, 2022

Morning Bell 1 November

Sophia Mavridis
November 1, 2022

Closing Bell 31 October

Sophia Mavridis
November 1, 2022